Erratum to: Metabolic response to 36 hours of fasting in young men born small vs appropriate for gestational age [Diabetologia, (2014), DOI 10.1007/s00125-014-3406-6];Metabolic response to 36 hours of fasting in young men born small vs appropriate for gestational age

Diabetologia

Volumn 58, Issue 1, 2015, Pages 178-187

  Jørgensen, Sine W ^a,b   Brøns, Charlotte ^a   Bluck, Les ^c   Hjort, Line ^a   Færch, Kristine ^b   Thankamony, Ajay ^d   Gillberg, Linn ^a   Friedrichsen, Martin ^e   Dunger, David B ^f   Vaag, Allan A ^a  

^a Rigshospitalet   (Denmark)

^b STENO DIABETES CENTER   (Denmark)

^c MRC HUMAN NUTRITION RESEARCH   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

DNA methylation; Insulin resistance; Low birthweight; Prolonged fasting; Small for gestational age

Indexed keywords

DNA; FAT; GLUCOSE; GLYCOGEN; INSULIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA C1A; STABLE ISOTOPE; TRACER; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; GLUCOSE BLOOD LEVEL;

ADIPOSE TISSUE; ADULT; ANTHROPOMETRY; APPROPRIATE FOR GESTATIONAL AGE; ARTICLE; BLOOD SAMPLING; CALORIMETRY; CARDIOMETABOLIC RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DNA METHYLATION; ENERGY CONSERVATION; FATTY ACID OXIDATION; GESTATIONAL AGE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLYCOGEN MUSCLE LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; MALE; METABOLISM; MUSCLE BIOPSY; PROTEIN EXPRESSION; SERUM; SMALL FOR DATE INFANT; TRIACYLGLYCEROL BLOOD LEVEL; YOUNG ADULT; ADAPTATION; BIRTH WEIGHT; CONTROLLED CLINICAL TRIAL; ENERGY METABOLISM; FEMALE; INSULIN RESISTANCE; NEWBORN; PHYSIOLOGY; PREGNANCY; TIME FACTOR;

ADAPTATION, PHYSIOLOGICAL; ADULT; BIRTH WEIGHT; BLOOD GLUCOSE; ENERGY METABOLISM; FASTING; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; INSULIN RESISTANCE; MALE; PREGNANCY; TIME FACTORS; YOUNG ADULT;

EID: 84916593864     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-014-3432-4     Document Type: Erratum

References (39)

1. Vaag AA, Grunnet LG, Arora GP, Brøns C (2012) The thrifty phenotype hypothesis revisited. Diabetologia 55:2085–2088
2. Brøns C, Jensen CB, Storgaard H et al (2008) Mitochondrial function in skeletal muscle is normal and unrelated to insulin action in young men born with low birth weight. J Clin Endocrinol Metab 93:3885–3892
3. Hermann TS, Rask-Madsen C, Ihlemann N et al (2003) Normal insulin-stimulated endothelial function and impaired insulin-stimulated muscle glucose uptake in young adults with low birth weight. J Clin Endocrinol Metab 88:1252–1257
4. Vielwerth SE, Jensen RB, Larsen T et al (2008) The effect of birthweight upon insulin resistance and associated cardiovascular risk factors in adolescence is not explained by fetal growth velocity in the third trimester as measured by repeated ultrasound fetometry. Diabetologia 51:1483–1492
5. Garg M, Thamotharan M, Dai Y et al (2012) Early postnatal caloric restriction protects adult male intrauterine growth-restricted offspring from obesity. Diabetes 61:1391–1398
6. Rasmussen EL, Malis C, Jensen CB et al (2005) Altered fat tissue distribution in young adult men who had low birth weight. Diabetes Care 28:151–153
7. Brøns C, Jacobsen S, Hiscock N et al (2012) Effects of high-fat overfeeding on mitochondrial function, glucose and fat metabolism, and adipokine levels in low-birth-weight subjects. Am J Physiol Endocrinol Metab 302:E43–E51
8. Jensen CB, Storgaard H, Dela F, Holst JJ, Madsbad S, Vaag AA (2002) Early differential defects of insulin secretion and action in 19-year-old Caucasian men who had low birth weight. Diabetes 51:1271–1280
9. Alibegovic AC, Højbjerre L, Sonne MP et al (2010) Increased rate of whole body lipolysis before and after 9 days of bed rest in healthy young men born with low birth weight. Am J Physiol Endocrinol Metab 298:E555–E564
10. Ozanne S, Jensen C, Tingey K et al (2006) Decreased protein levels of key insulin signalling molecules in adipose tissue from young men with a low birthweight: potential link to increased risk of diabetes? Diabetologia 49:2993–2999
11. Ozanne SE, Jensen CB, Tingey KJ, Storgaard H, Madsbad S, Vaag AA (2005) Low birthweight is associated with specific changes in muscle insulin-signalling protein expression. Diabetologia 48:547–552
12. Brøns C, Jacobsen S, Nilsson E et al (2010) Deoxyribonucleic acid methylation and gene expression of PPARGC1A in human muscle is influenced by high-fat overfeeding in a birth-weight-dependent manner. J Clin Endocrinol Metab 95:3048–3056
13. Gillberg L, Jacobsen SC, Ronn T, Brons C, Vaag A (2014) PPARGC1A DNA methylation in subcutaneous adipose tissue in low birth weight subjects—impact of 5 days of high-fat overfeeding. Metabolism 63:263–271
14. Jensen CB, Storgaard H, Madsbad S, Richter EA, Vaag AA (2007) Altered skeletal muscle fiber composition and size precede whole-body insulin resistance in young men with low birth weight. J Clin Endocrinol Metab 92:1530–1534
15. Mortensen B, Hingst JR, Frederiksen N et al (2013) Effect of birth weight and 12 weeks of exercise training on exercise-induced AMPK signaling in human skeletal muscle. Am J Physiol Endocrinol Metab 304:E1379–E1390
16. Finck BN, Kelly DP (2006) PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J Clin Invest 116:615–622
17. Patti ME, Butte AJ, Crunkhorn S et al (2003) Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A 100:8466–8471
18. Mootha VK, Lindgren CM, Eriksson KF et al (2003) PGC-1á-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34:267–273
19. Frayn KN (1983) Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 55:628–634
20. Polonsky KS, Rubenstein AH (1984) C-peptide as a measure of the secretion and hepatic extraction of insulin. Pitfalls and limitations. Diabetes 33:486–494
21. Abdul-Ghani MA, Matsuda M, Balas B, DeFronzo RA (2007) Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care 30:89–94
22. Bergman RN, Phillips LS, Cobelli C (1981) Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 68:1456–1467
23. Hales CN, Barker DJ, Clark PM et al (1991) Fetal and infant growth and impaired glucose tolerance at age 64. BMJ 303:1019–1022
24. Harder T, Rodekamp E, Schellong K, Dudenhausen JW, Plagemann A (2007) Birth weight and subsequent risk of type 2 diabetes: a meta-analysis. Am J Epidemiol 165:849–857
25. Valdez R, Athens MA, Thompson GH, Bradshaw BS, Stern MP (1994) Birthweight and adult health outcomes in a biethnic population in the USA. Diabetologia 37:624–631
26. Poulsen P, Vaag AA, Kyvik KO, Moller JD, Beck-Nielsen H (1997) Low birth weight is associated with NIDDM in discordant monozygotic and dizygotic twin pairs. Diabetologia 40:439–446
27. Portha B, Chavey A, Movassat J (2011) Early-life origins of type 2 diabetes: fetal programming of the beta-cell mass. Exp Diabetes Res 2011:105076
28. Kolovou GD, Mikhailidis DP, Kovar J et al (2011) Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement. Curr Vasc Pharmacol 9:258–270
29. Sparks JD, Sparks CE, Adeli K (2012) Selective hepatic insulin resistance, VLDL overproduction, and hypertriglyceridemia. Arterioscler Thromb Vasc Biol 32:2104–2112
30. Norrelund H, Nair KS, Jorgensen JO, Christiansen JS, Moller N (2001) The protein-retaining effects of growth hormone during fasting involve inhibition of muscle-protein breakdown. Diabetes 50:96–104
31. Zauner C, Schneeweiss B, Kranz A et al (2000) Resting energy expenditure in short-term starvation is increased as a result of an increase in serum norepinephrine. Am J Clin Nutr 71:1511–1515
32. Højbjerre L, Alibegovic AC, Sonne MP et al (2011) Increased lipolysis but diminished gene expression of lipases in subcutaneous adipose tissue of healthy young males with intrauterine growth retardation. J Appl Physiol 111:1863–1870
33. Ferland-McCollough D, Fernandez-Twinn DS, Cannell IG et al (2012) Programming of adipose tissue miR-483–3p and GDF-3 expression by maternal diet in type 2 diabetes. Cell Death Differ 19:1003–1012
34. de Zegher F, Diaz M, Sebastiani G et al (2012) Abundance of circulating preadipocyte factor 1 in early life. Diabetes Care 35:848–849
35. Randle PJ, Garland PB, Hales CN, Newsholme EA (1963) The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1:785–789
36. Barres R, Osler ME, Yan J et al (2009) Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density. Cell Metab 10:189–198
37. Ling C, del Guerra S, Lupi R et al (2008) Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion. Diabetologia 51:615–622
38. Wu Z (1999) Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98:115–124
39. Zeng Y, Gu P, Liu K, Huang P (2013) Maternal protein restriction in rats leads to reduced PGC-1alpha expression via altered DNA methylation in skeletal muscle. Mol Med Rep 7:306–312